BIRC5 and Miyoshi myopathy: compared immunogenicity of the rate-limiting catalytic subunit of the telomerase complex called hTERT (60) and anti-apoptotic protein survivin as a target antigen vaccine to pneumococcal conjugate vaccine in 54 MM patients.